1 Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al.; ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–128.
2 Calderwood SB, Swinski LA, Waternaux CM, Karchmer AW, Buckley MJ. Risk factors for the development of prosthetic valve endocarditis. Circulation. 1985;72:31–7.
3 Gilbert ND, Chambers HF, Eliopoulos G, Saag, MS, Pavia AT, Black D, et al., editors. Sanford Guide to antimicrobial therapy 2019. 49th ed. Sperryville: Antimicrobial Therapy, Inc.; 2019.
4 Wang A, Athan E, Pappas PA, Fowler Jr VG, Olaison L, Paré C, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297(12):1354–61.
5 Mihos CG, Capoulade R, Yucel E, Picard MH, Santana O. Surgical versus medical therapy for prosthetic valve endocarditis: A meta-analysis of 32 Studies. Ann Thorac Surg. 2017; 103(3):991–1004.
6 Attaran S, Chukwuemeka A, Punjabi P, Anderson J. Do all patient with prosthetic valve endocarditis need surgery? Interact Cardiovasc Thorac Surg. 2012:15(6):1057–61.
7 Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni E, et al. for the International Collaboration on Endocarditis-Prospective Cohort Study Investigators. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med. 2013;173(16):1495–504.